Stay updated on Entrectinib vs Crizotinib in ROS1 NSCLC Clinical Trial

Sign up to get notified when there's something new on the Entrectinib vs Crizotinib in ROS1 NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Entrectinib vs Crizotinib in ROS1 NSCLC Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Revision tag updated from v3.3.3 to v3.3.4; no study data or page content changed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-14T02:53:06.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    A new history entry for Study Status was added on 2026-01-05 (reference date 2026-01-01, version 63). The entry dated 2025-12-04 was removed.
    Difference
    0.2%
    Check dated 2026-01-07T00:52:20.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    28 days ago
    Change Detected
    Summary
    The version history now includes a new entry 'Revision: v3.3.3'. Entries for 'HHS Vulnerability Disclosure' and 'Revision: v3.3.2' were removed.
    Difference
    0.1%
    Check dated 2025-12-23T17:25:45.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    Added a new version on 2025-12-04 updating the Study Status and Contacts/Locations; the 2025-11-04 entry was removed.
    Difference
    0.3%
    Check dated 2025-12-09T01:25:40.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    A new revision entry v3.3.2 was added to the history and the previous revision v3.2.0 was removed.
    Difference
    0.1%
    Check dated 2025-11-24T21:55:23.000Z thumbnail image
  7. Check
    63 days ago
    Change Detected
    Summary
    The page removed the government funding status notice. This change does not affect the study data, status, or records displayed on the page.
    Difference
    0.4%
    Check dated 2025-11-17T20:04:40.000Z thumbnail image

Stay in the know with updates to Entrectinib vs Crizotinib in ROS1 NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Entrectinib vs Crizotinib in ROS1 NSCLC Clinical Trial page.